Anagrelide-<wbr/><sup>13</sup>C<sub>3</sub>

Anagrelide-13C3

CAT N°: 33280
Price:

From 236.00 200.60

Anagrelide-13C3 is intended for use as an internal standard for the quantification of anagrelide (Item No. 21411) by GC- or LC-MS. Anagrelide is an inhibitor of phosphodiesterase 3 (PDE3; IC50 = 36 nM for the human platelet enzyme).{54743} It inhibits thrombopoietin-induced megakaryocytopoiesis of isolated human CD34+ progenitor cells (IC50 = 26 nM).{54744} Anagrelide reduces platelet aggregation induced by ADP, collagen, thrombin, or arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in isolated rabbit platelet rich-plasma (EC50s = 0.31, 0.08, 0.18, and 0.1 µg/ml, respectively).{54745} It inhibits platelet thrombus formation in a dog model of electrically induced carotid artery thrombosis when administered at doses ranging from 0.5 to 5 mg/kg.{54746} Formulations containing anagrelide have been used in the treatment of thrombocythemia.

We also advise you